{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:38:36Z","timestamp":1791923916451,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1007\/s10741-005-2344-2","type":"journal-article","created":{"date-parts":[[2005,6,9]],"date-time":"2005-06-09T13:35:03Z","timestamp":1118324103000},"page":"15-22","source":"Crossref","is-referenced-by-count":209,"title":["Mineralocorticoid Receptors: Distribution and Activation"],"prefix":"10.1007","volume":"10","author":[{"given":"John W.","family":"Funder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"2344_CR1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF02155834","volume":"9","author":"S Simpson","year":"1953","unstructured":"Simpson S, Tait J, Wettstein A, Neher R, von Euw J, Reichstein T. Isolierung eines neuen kristallisierten Hormons aus Nebennerien mit besonders hoher Wirksamkeit auf den Mineralsoffwechsel. Experientia 1953;9:333\u2013335.","journal-title":"Experientia"},{"key":"2344_CR2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0022-4731(72)90053-2","volume":"3","author":"G Rousseau","year":"1972","unstructured":"Rousseau G, Baxter J, Funder J, Edelman I, Tomkins G. Glucocorticoid and mineralocorticoid receptors for aldosterone. J Steroid Biochem 1972;3:219\u2013227.","journal-title":"J Steroid Biochem"},{"key":"2344_CR3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-4731(72)90052-0","volume":"3","author":"JW Funder","year":"1972","unstructured":"Funder JW, Feldman D, Edelman IS. Specific aldosterone binding in rat kidney and parotid. J Steroid Biochemistry 1972;3:209\u2013218.","journal-title":"J Steroid Biochemistry"},{"key":"2344_CR4","first-page":"992","volume":"92","author":"JW Funder","year":"1973","unstructured":"Funder JW, Feldman D, Edelman IS. The roles of plasma binding and receptor specificity in the mineralocorticoid action of aldosterone. Endocrinology 1973;92:992\u20131004.","journal-title":"Endocrinology"},{"key":"2344_CR5","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1073\/pnas.71.4.1431","volume":"71","author":"D Marver","year":"1974","unstructured":"Marver D, Stewart J, Funder JW, Feldman D, Edelman IS. Renal aldosterone receptors: Studies with (3H) aldosterone and the anti-mineralocorticoid (3H) spirolactone (SC26304). Proc Natl Acad Sci USA 1974;71:1431\u20131435.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2344_CR6","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1152\/physrev.1986.66.4.1121","volume":"66","author":"BS McEwen","year":"1986","unstructured":"McEwen BS, De Kloet ER, Rostene W. Adrenal steroid receptors and actions in the nervous system. Physiol Rev 1986;66:1121\u20131188.","journal-title":"Physiol Rev"},{"key":"2344_CR7","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1073\/pnas.80.19.6056","volume":"80","author":"ZS Krozowski","year":"1983","unstructured":"Krozowski ZS, Funder JW. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 1983;80:6056\u20136060.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2344_CR8","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1210\/mend-3-11-1877","volume":"3","author":"PD Patel","year":"1989","unstructured":"Patel PD, Sherman TG, Goldman DJ, Watson SJ. Molecular cloning of a mineralocorticoid (type 1) receptor complementary DNA from rat hippocampus. Mol Endocrinol 1989;3:1877\u20131885.","journal-title":"Mol Endocrinol"},{"key":"2344_CR9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-4731(88)90251-8","volume":"29","author":"D Doyle","year":"1988","unstructured":"Doyle D, Krozowski Z, Morgan FJ, Funder JW. Analysis of renal and hippocampal Type I and Type II receptors by Fast Protein Liquid Chromatography. J Steroid Biochem 1988;29:415\u2013421.","journal-title":"J Steroid Biochem"},{"key":"2344_CR10","first-page":"131","volume":"4","author":"KH Berecek","year":"1982","unstructured":"Berecek KH, Barron KW, Webb RL, Brody MJ. Vasopressin-central nervous system interactions in the development of DOCA-hypertension. Hypertension 1982;4:131\u2013137.","journal-title":"Hypertension"},{"key":"2344_CR11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1440-1681.1987.tb02422.x","volume":"14","author":"P Pearce","year":"1987","unstructured":"Pearce P, Funder JW. High affinity aldosterone binding sites (Type 1 receptors) in rat heart. Clin Exp Pharmacol Physiol 1987;14:859\u2013866.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2344_CR12","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1210\/endo-125-4-2224","volume":"125","author":"JW Funder","year":"1989","unstructured":"Funder JW, Pearce PT, Smith R, Campbell J. Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors. Endocrinology 1989;125:2224\u20132226.","journal-title":"Endocrinology"},{"key":"2344_CR13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","volume":"237","author":"JL Arriza","year":"1987","unstructured":"Arriza JL, Weinberger C, Cerelli G, et al. Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor. Science 1987;237:268\u2013275.","journal-title":"Science"},{"key":"2344_CR14","first-page":"E601","volume":"270","author":"K Myles","year":"1996","unstructured":"Myles K, Funder JW. Progesterone binding to mineralocorticoid receptors: in vitro and in vivo studies. Amer J Physiol 1996;270:E601\u2013E607.","journal-title":"Amer J Physiol"},{"key":"2344_CR15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"RP Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M, et al. A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992;355:262\u2013265.","journal-title":"Nature"},{"key":"2344_CR16","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1210\/jc.2003-030353","volume":"88","author":"F Dunlop","year":"2003","unstructured":"Dunlop F, Crock P, Montalto J, Funder JW, Curnow K. A compound heterozygote case of type II aldosterone synthase deficiency. J Clin Endocrinol Metab 2003;88:2518\u20132526.","journal-title":"J Clin Endocrinol Metab"},{"key":"2344_CR17","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1073\/pnas.091553298","volume":"98","author":"JW Thornton","year":"2001","unstructured":"Thornton JW. Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions. Proc Natl Acad Sci USA 2001;98:5671\u20135676.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2344_CR18","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1210\/en.2003-0566","volume":"144","author":"A Greenwood","year":"2003","unstructured":"Greenwood A, Butler P, White R, DeMarco U, Pearce D, Fernald R. Multiple corticosteroid receptors in a teleost fish: Distinct sequences. Endocrinology 2003;144:4226\u20134236.","journal-title":"Endocrinology"},{"key":"2344_CR19","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1210\/en.2003-0843","volume":"144","author":"ME Baker","year":"2003","unstructured":"Baker ME. Evolution of glucocorticoid and mineralocorticoid responses: Go fish. Endocrinology 2003;144:4223\u20134225.","journal-title":"Endocrinology"},{"key":"2344_CR20","doi-asserted-by":"crossref","unstructured":"Sturm A, Bury N, Dengreville L, et al. 11-deoxycorticosterone is a potent agonist of the rainbow trout (Oncorhynchus mykiss) mineralocorticoid receptor. Endocrinology 2004:in press.","DOI":"10.1210\/en.2004-0128"},{"key":"2344_CR21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1126\/science.289.5476.119","volume":"289","author":"D Geller","year":"2000","unstructured":"Geller D, Farhi A, Pinkerton N, et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 2000;289:119\u2013123.","journal-title":"Science"},{"key":"2344_CR22","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1210\/jcem-44-5-924","volume":"44","author":"MI New","year":"1977","unstructured":"New MI, Levine LS, Biglieri EG, Pareira J, Ulick S. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J Clin Endocrinol Metab 1977;44:924\u2013933.","journal-title":"J Clin Endocrinol Metab"},{"key":"2344_CR23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(87)91014-2","volume":"2","author":"PM Stewart","year":"1987","unstructured":"Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 1987;2:821\u2013824.","journal-title":"Lancet"},{"key":"2344_CR24","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","volume":"242","author":"JW Funder","year":"1988","unstructured":"Funder JW, Pearce P, Smith R, Smith AI. Mineralocorticoid action: Target-tissue specificity is enzyme, not receptor, mediated. Science 1988;242:583\u2013585.","journal-title":"Science"},{"key":"2344_CR25","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","volume":"2","author":"CR Edwards","year":"1988","unstructured":"Edwards CR, Stewart PM, Burt D, et al. Localisation of 11 beta-hydroxysteroid dehydrogenase\u2014tissue specific protector of the mineralocorticoid receptor. Lancet 1988;2:986\u2013989.","journal-title":"Lancet"},{"key":"2344_CR26","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.206.4423.1139","volume":"206","author":"JW Funder","year":"1979","unstructured":"Funder JW. All really great lies are half true. Science 1979;206:1139.","journal-title":"Science"},{"key":"2344_CR27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0039-128X(94)90096-5","volume":"59","author":"J Funder","year":"1994","unstructured":"Funder J. Enzymes and receptors: Challenges and future directions. Steroids 1994;59:164\u2013169.","journal-title":"Steroids"},{"key":"2344_CR28","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1210\/endo.137.12.8940344","volume":"137","author":"JW Funder","year":"1996","unstructured":"Funder JW, Myles K. Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: In vivo binding studies. Endocrinology 1996;137:5264\u20135268.","journal-title":"Endocrinology"},{"key":"2344_CR29","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/01.HYP.35.5.1099","volume":"35","author":"R Alzamora","year":"2000","unstructured":"Alzamora R, Michea L, Marusic ET. Role of 11beta-hydroxysteroid dehydrogenase on nongenomic aldosterone effects in human arteries. Hypertension 2000;35:1099\u20131104.","journal-title":"Hypertension"},{"key":"2344_CR30","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1126\/science.1069300","volume":"295","author":"Q Zhang","year":"2002","unstructured":"Zhang Q, Piston D, Goodman R. Regulation of corepressor function by nuclear NADH. Science 2002;295:1895\u20131897.","journal-title":"Science"},{"key":"2344_CR31","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1073\/pnas.1633591100","volume":"100","author":"C Fjeld","year":"2003","unstructured":"Fjeld C, Birdsong W, Goodman R. Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor. Proc Natl Acad Sci USA 2003;100:9202\u20139207.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2344_CR32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/hc3001.091458","volume":"104","author":"MR Ward","year":"2001","unstructured":"Ward MR, Kanellakis P, Ramsey D, Funder JW, Bobik A. Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries. Circulation 2001;104:467\u2013472.","journal-title":"Circulation"},{"key":"2344_CR33","first-page":"893","volume":"120","author":"CG Brilla","year":"1992","unstructured":"Brilla CG, Weber KT. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med 1992;120:893\u2013901.","journal-title":"J Lab Clin Med"},{"key":"2344_CR34","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI117269","volume":"93","author":"M Young","year":"1994","unstructured":"Young M, Fullerton M, Dilley R, Funder J. Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest 1994;93:2578\u20132583.","journal-title":"J Clin Invest"},{"key":"2344_CR35","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1210\/en.2002-220120","volume":"143","author":"R Rocha","year":"2002","unstructured":"Rocha R, Martin-Berger C, Yang P, Scherrar R, Delyani J, McMahon E. Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart. Endocrinology 2002;143:4828\u20134836.","journal-title":"Endocrinology"},{"key":"2344_CR36","first-page":"H1802","volume":"283","author":"R Rocha","year":"2002","unstructured":"Rocha R, Rudolph A, Frierdich G, et al. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Amer J Physiol 2002;283:H1802\u2013H1810.","journal-title":"Amer J Physiol"},{"key":"2344_CR37","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","volume":"63","author":"ER Blasi","year":"2003","unstructured":"Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, McMahon EG. Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney International 2003;63:1791\u20131800.","journal-title":"Kidney International"},{"key":"2344_CR38","unstructured":"Mihailidou AS, Mardini M, Fraser T, Knights D, Funder JW. Agonist\/antagonist activity of cortisol in cardiomyocyte mineralocorticoid receptors is determined by redox state. 30th Annual Meeting of the International Aldosterone Conference, New Orleans, 2004."},{"key":"2344_CR39","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1210\/endo.137.10.8828470","volume":"137","author":"A Sato","year":"1996","unstructured":"Sato A, Funder JW. High glucose stimulates aldosterone-induced hypertrophy via Type I mineralocorticoid receptors in neonatal rat cardiomyocytes. Endocrinology 1996;137:4145\u20134153.","journal-title":"Endocrinology"},{"key":"2344_CR40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1210\/jcem-6-2-117","volume":"6","author":"H Selye","year":"1946","unstructured":"Selye H. The general adaptation syndrome and the disease of adaptation. J Clin Endocrinol 1946;6:117\u2013230.","journal-title":"J Clin Endocrinol"},{"key":"2344_CR41","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1210\/en.2002-220926","volume":"144","author":"M Young","year":"2003","unstructured":"Young M, Moussa L, Dilley R, Funder JW. Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: Effects of 11 beta-hydroxysteroid dehydrogenase inactivation. Endocrinology 2003;144:1121\u20131125.","journal-title":"Endocrinology"},{"key":"2344_CR42","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1210\/en.2004-0005","volume":"145","author":"MJ Young","year":"2004","unstructured":"Young MJ, Funder JW. Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in DOC\/salt rats. Endocrinology 2004;145:3153\u20133157.","journal-title":"Endocrinology"},{"key":"2344_CR43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","volume":"93","author":"W Qin","year":"2003","unstructured":"Qin W, Rudolph A, Bond B, et al. A transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circ Res 2003;93:69\u201376.","journal-title":"Circ Res"},{"key":"2344_CR44","unstructured":"Qin W, Bond BR, Donoho GP, et al. Mineralocorticoid receptor mediates heart failure in the 11beta-hydroxysteroid dehydrogenase type 2 transgenic mouse model. American Heart Association Scientific Sessions, New Orleans, 2004."},{"key":"2344_CR45","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","volume":"108","author":"B Pitt","year":"2003","unstructured":"Pitt B, Reichek N, Willenbrock R, et al. Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: The 4E-left ventricular hypertrophy study. Circulation 2003;108:1831\u20131838.","journal-title":"Circulation"},{"key":"2344_CR46","doi-asserted-by":"crossref","first-page":"24A","DOI":"10.1016\/S0895-7061(02)02333-6","volume":"15","author":"M Epstein","year":"2002","unstructured":"Epstein M, Buckalew V, Martinez F, et al. Antiproteinuric efficacy of eplerenone, enalapril and eplerenone\/enalapril combination in diabetic hypertensives with microalbuminuria. Am J Hypertens 2002;15:24A (abstract).","journal-title":"Am J Hypertens"},{"key":"2344_CR47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New Eng J Med 1999;341:709\u2013717.","journal-title":"New Eng J Med"},{"key":"2344_CR48","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New Engl J Med 2003;348:1309\u20131321.","journal-title":"New Engl J Med"},{"key":"2344_CR49","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/jc.2003-032149","volume":"89","author":"D Levy","year":"2004","unstructured":"Levy D, Rocha R, Funder JW. Distinguishing the antihypertensive and electrolyte effects of eplerenone. J Clin Endocrinol Metab 2004;89:2736\u20132740.","journal-title":"J Clin Endocrinol Metab"},{"key":"2344_CR50","first-page":"E482","volume":"258","author":"EP Gomez-Sanchez","year":"1990","unstructured":"Gomez-Sanchez EP, Fort CM, Gomez-Sanchez CE. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. Am J Physiol 1990;258:E482\u2013 E484.","journal-title":"Am J Physiol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-005-2344-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-005-2344-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-005-2344-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T08:33:20Z","timestamp":1706258000000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-005-2344-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["2344"],"URL":"https:\/\/doi.org\/10.1007\/s10741-005-2344-2","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}